Small cap stocks to watch: Aurora Cannabis, AGF, Chemtrade, Savaria and more

The article is a small-cap roundup featuring several stock-moving catalysts: Aurora Cannabis agreed to buy Safari Flower for $26.5 million, AGF Management reported a revenue and EPS miss with a $16.8 million fair value writedown, and Chemtrade fell after a rezoning rejection that threatens its chlor-alkali facility beyond 2030. Offsetting those negatives, Savaria issued first-quarter guidance above estimates and a five-year outlook for 12% annual top-line growth to about $1.6 billion by 2030, while Secure Waste surged on GFL’s $5.4 billion takeover offer at $24.75 per share. The piece also highlights multiple analyst target changes and an upcoming calendar of small-cap earnings.

Analysis

The biggest cross-asset signal here is not the individual beats/misses, but the widening dispersion inside Canadian small caps as capital rotates toward companies with visible self-help, hard assets, or deal optionality. That makes the market less forgiving for asset-light compounders with earnings volatility, while rewarding firms that can either de-risk execution through a takeover premium or credibly decompose growth into pricing, mix, and acquisitions. The result is a two-speed tape: “quality growth” with guidance leverage is being repriced higher, while anything with a one-quarter earnings hiccup and no imminent catalyst is getting de-rated aggressively.

Chemtrade is the most interesting setup because the selloff is being driven by a binary headline, but the real issue is timing asymmetry. Even if the permitting risk is ultimately resolved, the stock now trades with a higher implied probability of prolonged regulatory friction, which compresses the value of the chloride network far more than the market is likely to model on day one. That creates an opportunity for mean reversion only if management can quickly convert community support into a credible legal or political path; otherwise, this becomes a slow-burn overhang that caps multiple expansion for months.

On the upside, Savaria is the cleanest “compounding at scale” story in the group because the market can underwrite the next several years with relatively low macro sensitivity. A 20% margin framework plus acquisition-supported top-line growth is exactly the kind of visible operating model institutions will pay for, especially versus names whose earnings are being dragged around by advertising softness or one-off fair value marks. The contrarian risk is that the market may be too quick to extrapolate guidance credibility into a full re-rating before proving that organic growth can sustain without incremental M&A.

The deal winners are also subtler than the obvious premium capture: GFL likely gets a cleaner equity story if the transaction closes, because the added scale and float can expand index relevance and improve liquidity, which matters more than the immediate EPS math. For Aurora, the acquisition is strategically sensible but economically modest; the market is likely rewarding capacity rather than near-term earnings, so the upside depends on whether international supply can actually translate into higher-priced product mix rather than just more volume.

Key Decisions for Investors

• Long SES.TO / short a basket of high-quality but catalyst-poor Canadian small caps for 1-3 months: the takeover premium and index/liquidity optionality should outperform names with no event path, with limited downside unless financing or regulatory risk emerges.
• Buy pullbacks in SIS.TO on any post-guidance consolidation, targeting a 6-12 month horizon: the stock should compound if management executes to plan, and the setup offers better downside protection than earnings-sensitive peers because the path is self-funding.
• Avoid/short AGFMF on strength into the next quarter: the stock likely needs multiple clean quarters to rebuild credibility, and fair value marks in alternatives can recur; risk/reward favors waiting for a better entry after the de-rating is fully digested.
• Tactically trade CHE.UN.TO as a volatility event, not a long-only hold: use a partial short or put spread for 1-2 months if permitting headlines remain unresolved, with a view that the market is underpricing timeline risk more than ultimate asset value.
• For ACB, treat the deal as a relative-value catalyst rather than a fundamental breakout: prefer a short-dated call structure only if management can show export revenue conversion, otherwise the market may fade the move once the capacity story is normalized.